Package 0409-5082-16

Brand: tazicef

Generic: ceftazidime
NDC Package

Package Facts

Identity

Package NDC 0409-5082-16
Digits Only 0409508216
Product NDC 0409-5082
Description

25 VIAL in 1 CARTON (0409-5082-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-5082-11)

Marketing

Marketing Status
Marketed Since 2005-11-02
Brand tazicef
Generic ceftazidime
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "a0763a23-5d1e-4fc3-9e3c-1a426fff42b0", "openfda": {"unii": ["9M416Z9QNR"], "rxcui": ["1659283", "1659287", "1659292", "1659294"], "spl_set_id": ["40d48c5d-650e-461b-a67b-7e65772d1b92"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (0409-5082-16)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0409-5082-11)", "package_ndc": "0409-5082-16", "marketing_start_date": "20051102"}], "brand_name": "TAZICEF", "product_id": "0409-5082_a0763a23-5d1e-4fc3-9e3c-1a426fff42b0", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "0409-5082", "generic_name": "CEFTAZIDIME", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZICEF", "active_ingredients": [{"name": "CEFTAZIDIME", "strength": "1 g/1"}], "application_number": "ANDA062662", "marketing_category": "ANDA", "marketing_start_date": "20051102", "listing_expiration_date": "20261231"}